Paper

SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccines

Surenaud, Mathieu, Zurawski, Gerard, Alexandre, Marie, Le Grand, Roger, Marlin, Romain, Naninck, Thibaut, Delache, Benoit, Galhaut, Mathilde, Maisonnasse, Pauline, Wiedemann, Aurelie, Thiébaut, Rodolphe, Cardinaud, Sylvain, Dereuddre-Bosquet, Nathalie, Levy, Yves, Prague, Mélanie, Schwartz, Olivier, Coleon, Séverin, Cavarelli, Mariangela, Kahlaoui, Nidhal, Centlivre, Mireille, Lacabaratz, Christine, Sanders, Rogier W, Zurawski, Sandra

2021

Overview

The definition of correlates of protection is critical for the development of next generation SARS-CoV-2 vaccine platforms. Here, we propose a new framework for identifying mechanistic correlates of protection based on mathematical modelling of viral dynamics and data mining of immunological markers. The application to three different studies in non-human primates evaluating SARS-CoV-2 vaccines based on CD40-targeting, two-component spike nanoparticle and mRNA 1273 identifies and quantifies two main mechanisms that are a decrease of rate of cell infection and an increase in clearance of infected cells. Inhibition of RBD binding to ACE2 appears to be a robust mechanistic correlate of protection across the three vaccine platforms although not capturing the whole biological vaccine effect. The model shows that RBD/ACE2 binding inhibition represents a strong mechanism of protection which required significant reduction in blocking potency to effectively compromise the control of viral replication. A framework for modelling the immune control of viral dynamics is applied to quantify the effect of several SARS-CoV-2 vaccine platforms and to define mechanistic correlates of protection.

• Publisher: Cold Spring Harbor Laboratory
• Subject: Immunology